Royce & Associates LP Inogen Inc Transaction History

Royce & Associates LP

  • $10.5 Billion
  • Q3 2024

A detailed history of Royce & Associates LP transactions in Inogen Inc stock. As of the latest transaction made, Royce & Associates LP holds 51,891 shares of INGN stock, worth $495,559. This represents 0.0% of its overall portfolio holdings.

Number of Shares
51,891
Previous 19,409 167.36%
Holding current value
$495,559
Previous $157,000 220.38%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024
BUY
$7.67 - $12.98 $249,136 - $421,616
32,482 Added 167.36%
51,891 $503,000
Q2 2024

Aug 13, 2024
SELL
$6.3 - $8.95 $314,130 - $446,264
-49,862 Reduced 71.98%
19,409 $157,000
Q1 2024

May 13, 2024
BUY
$5.26 - $10.15 $364,365 - $703,100
69,271 New
69,271 $559,000
Q4 2021

Feb 07, 2022
SELL
$29.66 - $44.0 $140,973 - $209,132
-4,753 Closed
0 $0
Q3 2021

Nov 10, 2021
SELL
$43.09 - $82.26 $153,271 - $292,598
-3,557 Reduced 42.8%
4,753 $205,000
Q2 2021

Aug 06, 2021
SELL
$52.03 - $68.77 $48,439 - $64,024
-931 Reduced 10.07%
8,310 $542,000
Q1 2021

May 10, 2021
SELL
$43.96 - $55.99 $30,376 - $38,689
-691 Reduced 6.96%
9,241 $485,000
Q4 2020

Feb 08, 2021
BUY
$27.19 - $44.68 $19,359 - $31,812
712 Added 7.72%
9,932 $444,000
Q3 2020

Nov 12, 2020
BUY
$27.01 - $37.31 $10,749 - $14,849
398 Added 4.51%
9,220 $267,000
Q2 2020

Aug 07, 2020
SELL
$32.85 - $53.77 $530,888 - $868,976
-16,161 Reduced 64.69%
8,822 $313,000
Q1 2020

May 12, 2020
BUY
$32.63 - $67.59 $697,205 - $1.44 Million
21,367 Added 590.9%
24,983 $1.29 Million
Q4 2019

Feb 06, 2020
BUY
$45.95 - $76.15 $126,776 - $210,097
2,759 Added 321.94%
3,616 $247,000
Q3 2019

Nov 13, 2019
BUY
$41.82 - $66.71 $19,739 - $31,487
472 Added 122.6%
857 $41,000
Q2 2019

Aug 12, 2019
SELL
$63.19 - $95.15 $1.46 Million - $2.2 Million
-23,161 Reduced 98.36%
385 $26,000
Q1 2019

May 09, 2019
BUY
$90.12 - $152.23 $643,186 - $1.09 Million
7,137 Added 43.49%
23,546 $2.25 Million
Q4 2018

Feb 11, 2019
SELL
$112.83 - $239.74 $72,888 - $154,872
-646 Reduced 3.79%
16,409 $2.04 Million
Q3 2018

Nov 13, 2018
SELL
$189.1 - $282.92 $208,010 - $311,212
-1,100 Reduced 6.06%
17,055 $4.16 Million
Q2 2018

Aug 09, 2018
SELL
$123.8 - $192.48 $750,970 - $1.17 Million
-6,066 Reduced 25.04%
18,155 $3.38 Million
Q1 2018

May 14, 2018
SELL
$114.22 - $133.22 $456 - $532
-4 Reduced 0.02%
24,221 $2.98 Million
Q4 2017

Feb 09, 2018
SELL
$93.4 - $128.74 $93 - $128
-1 Reduced -0.0%
24,225 $2.89 Million
Q3 2017

Nov 13, 2017
SELL
$91.08 - $104.49 $1.72 Million - $1.98 Million
-18,929 Reduced 43.86%
24,226 $2.3 Million
Q2 2017

Aug 07, 2017
BUY
N/A
43,155
43,155 $4.12 Million

Others Institutions Holding INGN

# of Institutions
143
Shares Held
21M
Call Options Held
119K
Put Options Held
149K
View Full List

About Inogen Inc

INGN Quotes by TradingView
  • Ticker INGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 22,866,500
  • Market Cap $218M
  • Description
  • Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...
More about INGN
Track This Portfolio

Track Royce & Associates LP Portfolio

Follow Royce & Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email